Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

Clinical trial NCT00345579 · COMPLETED

Trial details

NCT number: NCT00345579
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Neisseria Meningitidis

Start date: 2006-09-01
Primary completion: 2007-10-01
Enrollment: 4432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.